ES2193379T3 - Combinacion de un analogo de somatostatina y de una rapamicina. - Google Patents

Combinacion de un analogo de somatostatina y de una rapamicina.

Info

Publication number
ES2193379T3
ES2193379T3 ES97928175T ES97928175T ES2193379T3 ES 2193379 T3 ES2193379 T3 ES 2193379T3 ES 97928175 T ES97928175 T ES 97928175T ES 97928175 T ES97928175 T ES 97928175T ES 2193379 T3 ES2193379 T3 ES 2193379T3
Authority
ES
Spain
Prior art keywords
combination
rapamycin
somatostatine
analog
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97928175T
Other languages
English (en)
Inventor
Gisbert Weckbecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH Austria
Novartis AG
Original Assignee
Novartis Pharma GmbH Austria
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612171.0A external-priority patent/GB9612171D0/en
Priority claimed from GBGB9619310.7A external-priority patent/GB9619310D0/en
Application filed by Novartis Pharma GmbH Austria, Novartis AG filed Critical Novartis Pharma GmbH Austria
Application granted granted Critical
Publication of ES2193379T3 publication Critical patent/ES2193379T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA COMBINACION DE UN COMPUESTO DE CLASE SOMATOSTATINA Y MACROLIDO DE RAPAMICINA ES UTIL PARA LA PREVENCION O TRATAMIENTO DE HIPERPROLIFERACION DE CELULAS
ES97928175T 1996-06-11 1997-06-11 Combinacion de un analogo de somatostatina y de una rapamicina. Expired - Lifetime ES2193379T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612171.0A GB9612171D0 (en) 1996-06-11 1996-06-11 Organic compounds
GBGB9619310.7A GB9619310D0 (en) 1996-09-16 1996-09-16 Organic compounds

Publications (1)

Publication Number Publication Date
ES2193379T3 true ES2193379T3 (es) 2003-11-01

Family

ID=26309485

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97928175T Expired - Lifetime ES2193379T3 (es) 1996-06-11 1997-06-11 Combinacion de un analogo de somatostatina y de una rapamicina.

Country Status (10)

Country Link
US (1) US6362164B1 (es)
EP (1) EP0896544B1 (es)
JP (1) JP3784418B2 (es)
AT (1) ATE233098T1 (es)
AU (1) AU3257297A (es)
CA (1) CA2249439C (es)
DE (1) DE69719320T2 (es)
DK (1) DK0896544T3 (es)
ES (1) ES2193379T3 (es)
WO (1) WO1997047317A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100558131B1 (ko) 1999-03-29 2006-03-10 더 프록터 앤드 갬블 캄파니 멜라노코르틴 수용체 리간드를 함유하는 약제학적 조성물및 멜라노코르틴 수용체 리간드를 함유하는 약제의제조방법
ES2167189B1 (es) * 1999-12-17 2003-04-01 Lipotec Sa Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
ATE475418T1 (de) * 2000-01-14 2010-08-15 Univ Pennsylvania O-methylierte rapamycinderivate zur milderung oder vermeidung lymphoproliferativer erkrankungen
DK3351246T3 (da) * 2001-02-19 2019-06-03 Novartis Pharma Ag Rapamycinderivat til behandling af en solid tumor, som er associeret med dereguleret angionese
AU2005201004A1 (en) * 2001-02-19 2005-03-24 Novartis Ag Cancer treatment
AU2011226833B9 (en) * 2001-02-19 2014-07-03 Novartis Ag Cancer treatment
AU2016206379B2 (en) * 2001-02-19 2017-09-14 Novartis Ag Cancer Treatment
FI20031454A0 (fi) 2003-10-06 2003-10-06 Juvantia Pharma Ltd Oy Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja
EP1522311A1 (fr) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée
MXPA06012404A (es) * 2004-04-27 2007-01-17 Wyeth Corp Marcado de rapamicina usando metilasas especificas de rapamicina.
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
PT1787658E (pt) 2005-11-10 2012-06-22 Chemi Spa Formulações de libertação sustentada de análogos de somatostatina inibidores da hormona do crescimento
ES2481671T3 (es) * 2005-11-21 2014-07-31 Novartis Ag Inhibidores de mTOR en el tratamiento de tumores endocrinos
JP2009254391A (ja) * 2006-07-18 2009-11-05 Tetsuhiko Katsumata ゴルフのボールマーカー用ホルダー及びアクセサリー
WO2012013190A2 (en) 2010-07-29 2012-02-02 Linak A/S Lifting column preferably for height-adjustable tables
RU2644635C2 (ru) * 2011-07-07 2018-02-13 Рисёрч Кансер Инститьют Оф Америка Системы, способы и составы для лечения рака
US8933078B2 (en) 2011-07-14 2015-01-13 Research Cancer Institute Of America Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
US11890292B2 (en) 2017-02-27 2024-02-06 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
US11369585B2 (en) 2017-03-17 2022-06-28 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
WO2019099750A1 (en) 2017-11-17 2019-05-23 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
JP7099717B2 (ja) 2019-09-30 2022-07-12 株式会社理研バイオ ソマトスタチン受容体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2239178B (en) 1987-07-10 1991-11-27 Sandoz Ltd Somatostatin analogues for the treatment of breast cancer
GB9125660D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compound

Also Published As

Publication number Publication date
EP0896544A1 (en) 1999-02-17
JP3784418B2 (ja) 2006-06-14
DE69719320D1 (de) 2003-04-03
ATE233098T1 (de) 2003-03-15
JP2000514415A (ja) 2000-10-31
DE69719320T2 (de) 2003-12-11
EP0896544B1 (en) 2003-02-26
CA2249439C (en) 2009-09-08
WO1997047317A1 (en) 1997-12-18
AU3257297A (en) 1998-01-07
US6362164B1 (en) 2002-03-26
DK0896544T3 (da) 2003-05-05
CA2249439A1 (en) 1997-12-18

Similar Documents

Publication Publication Date Title
ES2193379T3 (es) Combinacion de un analogo de somatostatina y de una rapamicina.
PT914103E (pt) Tratamento de uma hemoglobinopatia
GB9507862D0 (en) Fabrication of organic light-emitting devices
DE69636902D1 (de) Lactacystin-analoge
HU9702035D0 (en) Leukocita-adhesion-inhibitor and vla-4-antagonist compounds containing 5-member ring
GB9509895D0 (en) Engaging structure of retainer
IL116724A (en) Substituted oxazolidine calpain and/or cathepsin B inhibitors
FI953483A7 (fi) Jätekaasuöljyn käsittely
ES2186807T3 (es) Inhibidores de trombina.
DE69737718D1 (de) Nachweis von mikroorganismen
ZA9810027B (en) Treatment of organic materials.
ID17472A (id) Sekat pencegah kebocoran
GB2286716B (en) The treatment of solid wastes
NO961619D0 (no) Spylekammer
FI944848A7 (fi) Fenyylisubstituoidut sykloalkyylihydroksiureajohdannaiset, jotka inhib oivat lipoksygenaasia
AU1979397A (en) Peptidomimetics for the treatment of hiv infection
GB9222590D0 (en) The treatment of solid organic wastes
GB9424471D0 (en) Treatment of emesis
KR970006285U (ko) 누수 방지용 볼트구조
GB9503795D0 (en) Use of organic compounds
ZA968923B (en) The treatment of sewage
GB9218641D0 (en) Wells sewage treatment
SE9400471D0 (sv) En komponent bestående av fortsättnings möjligen en uppfattningskomponent el observeringskomponent
IL135937A0 (en) The different uses of non-immunosuppressive compounds
KR970015351U (ko) 배터리 누유방지구조